JACQUELINE HENNIGAR: Open Payments
NPI 1396434460 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,295 in 142 payments from 29 companies in 2025. Trend: 2023 $619 · 2024 $2,320 · 2025 $3,295
Food & beverage: $3,231Education: $64
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 24 | $393 |
| AstraZeneca Pharmaceuticals LP | 9 | $392 |
| HARMONY BIOSCIENCES LLC | 8 | $261 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $236 |
| Axsome Therapeutics, Inc. | 12 | $219 |
| Verona Pharma, Inc. | 7 | $169 |
| Insmed, Inc. | 7 | $151 |
| GENZYME CORPORATION | 8 | $142 |
| Viatris Specialty LLC | 7 | $141 |
| Electromed, Inc. | 9 | $129 |
Products named: NUCALA, WAKIX, FASENRA, Sunosi, GLASSIA, DUPIXENT, Ohtuvayre, Arikayce.
Industry payments across CT — which companies pay providers there.
